© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Annovis Bio, Inc. (ANVS) shows an Average True Range (ATR) of 0.42 and an Enterprise Value of 134.53M. Its average trading volume over the past 3 months is 1.87M, indicating liquidity. These fundamental metrics provide insight into ANVS's underlying financial health and market activity.
Annovis Bio, Inc. (ANVS) technical indicators as of December 22, 2025: the SMA 20 is -14.14%, SMA 50 at 20.37%, and SMA 200 at 52.32%. The RSI 14 value is 48.3, suggesting its current momentum. These technical analysis signals help assess ANVS's price trends and potential future movements.
Annovis Bio, Inc. (ANVS) stock performance overview as of December 22, 2025: The 52-week high is $5.6 (currently -34.82% below), and the 52-week low is $1.11 (currently 228.83% above). Over the past year, ANVS's performance is -31.26%, compared to the S&P 500's 12.87% change.
According to market data, Annovis Bio, Inc. (ANVS) stock's recent performance metrics show that over the last month, ANVS is 8.31%, with a Year-to-Date (YTD) performance of -27.44%. Over the past year, the stock has seen a -31.26% change. These figures summarize ANVS's price movements across various periods, reflecting its historical returns.
According to current financial data, ANVS stock's P/E (TTM) ratio is -2.35, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ANVS, including P/S (N/A), P/B (0.00), and P/FCF (-0.01), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.